CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-19 | Brooks Gabriel Chief Medical Officer | Sale 10b5-1 | −4,374 | $5.62 | $25K | 97,241 |
| 2026-10-18 | Brooks Gabriel Chief Medical Officer | Option exercise 10b5-1 | +9,750 | 101,615 | ||
| 2026-10-18 | Brooks Gabriel Chief Medical Officer | Option exercise · Restricted Stock Units 10b5-1 | −9,750 | 9,750 | ||
| 2026-02-18 | Brooks Gabriel Chief Medical Officer | Sale 10b5-1 | −0 | $5.82 | $0 | 89,466 |
| 2026-02-13 | Brooks Gabriel Chief Medical Officer | Option exercise 10b5-1 | +10,937 | 95,029 | ||
| 2026-02-13 | Brooks Gabriel Chief Medical Officer | Option exercise · Restricted Stock Units 10b5-1 | −10,937 | 21,876 | ||
| 2026-02-04 | Brooks Gabriel Chief Medical Officer | Sale 10b5-1 | −12,616 | $6.44 | $81K | 84,092 |
| 2026-02-02 | Brooks Gabriel Chief Medical Officer | Sale 10b5-1 | −28,335 | $6.44 | $182K | 96,708 |
| 2026-01-31 | Brooks Gabriel Chief Medical Officer | Option exercise 10b5-1 | +28,225 | 125,043 | ||
| 2026-01-31 | Brooks Gabriel Chief Medical Officer | Option exercise · Restricted Stock Units 10b5-1 | −28,225 | 84,675 | ||
| 2026-01-29 | Brooks Gabriel Chief Medical Officer | Grant or award · Restricted Stock Units 10b5-1 | +58,847 | 58,847 | ||
| 2026-01-29 | Brooks Gabriel Chief Medical Officer | Option exercise 10b5-1 | +58,847 | 96,818 | ||
| 2026-01-29 | Brooks Gabriel Chief Medical Officer | Option exercise · Performance Stock Units 10b5-1 | −58,847 | 0 | ||
| 2026-01-29 | Brooks Gabriel Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) 10b5-1 | +207,450 | 207,450 | ||
| 2026-01-29 | Brooks Gabriel Chief Medical Officer | Grant or award · Restricted Stock Units 10b5-1 | +103,750 | 103,750 | ||
| 2025-10-20 | Brooks Gabriel Chief Medical Officer | Sale | −2,895 | $5.96 | $17K | 33,819 |
| 2025-10-18 | Brooks Gabriel Chief Medical Officer | Option exercise | +9,750 | 36,714 | ||
| 2025-10-18 | Brooks Gabriel Chief Medical Officer | Option exercise · Restricted Stock Units | −9,750 | 19,500 | ||
| 2025-08-14 | Brooks Gabriel Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +142,500 | 142,500 | ||
| 2025-08-14 | Brooks Gabriel Chief Medical Officer | Grant or award · Restricted Stock Units | +71,250 | 71,250 |
Page 1 of 2 · 24 trades